Key Takeaways Mounjaro contains tirzepatide , a dual GIP and GLP-1 receptor agonist, while Wegovy contains semaglutide , a single GLP-1 receptor agonist Mounjaro generally produces stronger results in body composition management compared to Wegovy in head-to-head studies Both medications work by reducing appetite and helping you feel fuller for longer, supporting metabolic health goals UK clinic costs are prohibitive : Mounjaro typically costs 300+ monthly, Wegovy around 250+ monthly through private providers Affordable tirzepatide alternatives exist : Tirzeparo offers the same active ingredient at 169-229 monthly with discreet EU delivery Dosing schedules differ : Mounjaro starts at 2.5mg weekly and increases gradually
However, and this is where the nuance really comes into play, the underlying condition for which you are taking Tirzepatide often dictates eligibility
At first glance, the difference seems minor
There have been times Ive struggled to take it but Ill stay on it for as long as Im told to by the medical team, she says
Prasad, C
Dependency Concerns: Prolonged use may create dependency on the tablets, where discontinuation could lead to a reversal of the lightening effects, making it crucial to weigh the long-term commitment
.webp)
